🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

National Database on Primary Biliary Cholangitis

Recruitingn/aAges 18 Years - anyAllUniversity of Milano Bicocca
NCT05151809 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary biliary cholangitis (PBC) is a rare, autoimmune, cholestatic liver disease. No data about the disease epidemiology exist in Italy. Therefore this study aims to develop a national PBC patient database linked to a biological sample storage.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: All PBC patients living in Italy and aged at least 18 years can be included in the database. According to well-established criteria, PBC is diagnosed in subjects who fulfill two of the three of following criteria: * elevated alkaline phosphatase and /or GGT; * positive anti-mitochondrial autoantibodies (titer ≥ 1:40) or PBC-specific antinuclear antibodies (gp-210 and sp100); * characteristic histological features of florid bile ducts lesions and granulomatous lesion. Exclusion Criteria: The patient has explicitly declared his/her unwillingness to participate to the study
💊

What it tests

  • Clinical information
📍

Where

55 sites
Ospedali riuniti di Ancona
Ancona, Italy
A.O.U. Consorziale - Policlinico Bari- UO Gastroenterologia
Bari, Italy
UO di gastroenterologia, Asst Papa Giovanni XXIII
Bergamo, Italy
Policlinico S. Orsola Malpighi- UO Medicina Interna
Bologna, Italy
Policlinico S.Orsola Malpighi- Ambulatorio di epatologia e gestione trapianto epatico
Bologna, Italy
Gastroenterologia, fisiopatologia e endoscopia digestiva, Azienda sanitaria dell'alto adige
Bolzano, Italy
Unità epatologica ed ecografia internistica a valenza dipartimentale, Fondazione Ospedaliera Poliambulanza
Brescia, Italy
UO di gastroenterologia, Spedali civili di Brescia
Brescia, Italy

…and 47 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy